↓ Skip to main content

Dove Medical Press

Costs of chronic obstructive pulmonary disease in urban areas of China: a cross-sectional study in four cities

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, October 2016
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
41 Mendeley
Title
Costs of chronic obstructive pulmonary disease in urban areas of China: a cross-sectional study in four cities
Published in
International Journal of Chronic Obstructive Pulmonary Disease, October 2016
DOI 10.2147/copd.s118523
Pubmed ID
Authors

Xiaoying Chen, Na Wang, Yue Chen, Tian Xiao, Chaowei Fu, Biao Xu

Abstract

The economic burden of COPD has not been well studied in China. This study investigated the total costs caused by COPD and the influencing factors for the high economic burden in urban areas of China. A cross-sectional study was carried out among 678 COPD patients in four cities in China in 2011. The average annual direct medical costs (DMCs), direct nonmedical costs (DNMCs), and indirect costs (ICs) on COPD were measured by median and mean (± standard deviation). Logistic regression model was used to explore factors related to high total costs on COPD. The median annual DMCs, DNMCs, and ICs per COPD patient were RMB 5565 Yuan (US$ 862), 0 Yuan (US$ 0), and 0 Yuan (US$ 0), respectively, and the mean annual DMCs, DNMCs, and ICs per COPD patient were RMB 11968 (±22422) Yuan [US$ 1853 (±3472)], 539 (±2092) Yuan [US$ 83 (±324)], and 2087 (±8110) Yuan [US$ 323 (±1256)], respectively. The annual DMCs, DNMCs, and ICs for diagnosed COPD patients were RMB 195.70 billion Yuan (US$ 30.30 billion), 8.78 billion Yuan (US$ 1.36 billion), and 34.10 billion Yuan (US$ 5.28 billion), respectively, in China. Hospitalization accounted for 56.7% of the total costs. High economic burden was significantly related to age, acute exacerbations, and disease severity in COPD patients. COPD posed a heavy economic burden in China. Measures to delay the disease progression and to reduce the risks of acute exacerbation and hospitalization will help substantially lower the costs for COPD care.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 2%
Unknown 40 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 20%
Researcher 7 17%
Student > Doctoral Student 4 10%
Student > Ph. D. Student 4 10%
Student > Postgraduate 3 7%
Other 5 12%
Unknown 10 24%
Readers by discipline Count As %
Medicine and Dentistry 13 32%
Pharmacology, Toxicology and Pharmaceutical Science 4 10%
Economics, Econometrics and Finance 3 7%
Social Sciences 3 7%
Nursing and Health Professions 2 5%
Other 5 12%
Unknown 11 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2018.
All research outputs
#7,205,295
of 25,374,647 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#824
of 2,577 outputs
Outputs of similar age
#103,155
of 332,576 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#33
of 96 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 2,577 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 332,576 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 96 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.